PTPN11 and juvenile myelomonocytic leukemia: Conversely, the correction of mutant PTPN11 in JMML-IPSCs via gene editing was shown to decrease the output of CD34+ hematopoietic progenitor cells to a level comparable with WT-IPSCs [21].